Andrew Hill

13PUBLICATIONS
39CO-AUTHORS
PharmacogenomicsPreventative health careCardiology (incl. cardiovascular diseases)Major global burdens of diseaseRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Mar 11, 2026
What Are the Causes and Consequences of Virological Failure on Long-acting Cabotegravir/Rilpivirine?

Andrew Hill, Chloe Orkin

|Dec 09, 2025
Is It Time to Reassess the Target Age of Human Papillomavirus Vaccination Globally?

Edie Brassington, Cassandra Fairhead, Andrew Hill

|Apr 09, 2025
The Need for Lenacapavir Compulsory Licences in Ending the HIV Epidemic.

Andrew Hill, Mark J Siedner, Cassandra Fairhead

|Jan 08, 2025
Safety and efficacy of long-acting cabotegravir/rilpivirine versus standard oral antiretroviral therapy: a systematic review and meta-analysis.

Samuel Bungaran Partahi Saud Manalu, Andrea Perez Navarro, Cassandra Fairhead

|Dec 26, 2024
Virologic Failure and Emergent Integrase Strand Transfer Inhibitor Drug Resistance With Long-Acting Cabotegravir for HIV Treatment: A Meta-analysis.

Andrea Perez Navarro, Cameron T Nutt, Mark J Siedner

|Jul 11, 2024
Challenges for Novel Antiretroviral Development in an Era of Widespread tenofovir-disoproxil/lamivudine (or emtricitabine)/dolutegravir availability (TLD) Availability.

Cassandra Fairhead, Jacob Levi, Andrew Hill

Pageof 3